Sarcoidosis Clinical Trials

25 recruiting

Sarcoidosis Trials at a Glance

48 actively recruiting trials for sarcoidosis are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Baltimore, Philadelphia, and Paris. Lead sponsors running sarcoidosis studies include Assistance Publique - Hôpitaux de Paris, Duke University, and Ottawa Heart Institute Research Corporation.

Browse sarcoidosis trials by phase

Treatments under study

About Sarcoidosis Clinical Trials

Looking for clinical trials for Sarcoidosis? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Sarcoidosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Sarcoidosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Not Applicable

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

Suspected Sarcoidosis
University Health Network, Toronto128 enrolled1 locationNCT06220526
Recruiting

Role of Genetic Factors in the Development of Lung Disease

AsthmaCystic FibrosisPulmonary Fibrosis+2 more
National Heart, Lung, and Blood Institute (NHLBI)3,500 enrolled2 locationsNCT00001532
Recruiting
Not Applicable

Virtual Patient Groups for Sarcoidosis Associated Fatigue

DepressionFatigueAnxiety+2 more
The Cleveland Clinic100 enrolled1 locationNCT07073963
Recruiting
Phase 1Phase 2

Feasibility of Semaglutide in Advanced Lung Disease

ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 2

Repurposing Tilmanocept for Cardiac Sarcoidosis

Cardiac Sarcoidosis
Duke University15 enrolled1 locationNCT07159074
Recruiting
Not Applicable

Corticosteroid Tapering in Sarcoidosis

Sarcoidosis
Royal Brompton & Harefield NHS Foundation Trust100 enrolled1 locationNCT07498842
Recruiting

Immunological Mechanisms in Sarcoidosis

Sarcoidosis
Region Stockholm5,000 enrolled1 locationNCT06576505
Recruiting

MoMa Signature During Granulomatosis

SarcoidosisTuberculosis
Assistance Publique - Hôpitaux de Paris100 enrolled1 locationNCT05916638
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Phase 3

Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis

Sarcoidosis
Assistance Publique - Hôpitaux de Paris90 enrolled1 locationNCT05689879
Recruiting
Not Applicable

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Lung Cancer (Diagnosis)Chronic Obstructive Pulmonary DiseaseSarcoidosis+2 more
Université Catholique de Louvain425 enrolled1 locationNCT07384897
Recruiting

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Noonan SyndromeFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07336394
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

Institutional Registry of Rare Diseases

ParagangliomaPheochromocytomaAmyloidosis+23 more
Hospital Italiano de Buenos Aires380 enrolled1 locationNCT06573723
Recruiting
Not Applicable

Cell Free DNA in Cardiac Sarcoidosis

HealthySarcoidosisST Elevation Myocardial Infarction+1 more
Nabeel Hamzeh120 enrolled2 locationsNCT03858777
Recruiting

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

Cardiac Sarcoidosis
University of Pennsylvania40 enrolled1 locationNCT06510894
Recruiting

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

Sarcoidosis, Pulmonary
University of California, San Francisco200 enrolled2 locationsNCT05567133
Recruiting
Phase 4

Vitamin D Homeostasis in Sarcoidosis

Sarcoidosis
University of Texas Southwestern Medical Center90 enrolled1 locationNCT03621553
Recruiting

Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens

Lung CancerSarcoidosis
Johns Hopkins University20 enrolled1 locationNCT05171478
Recruiting
Phase 2

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Pulmonary Sarcoidosis
Molecure S.A.96 enrolled28 locationsNCT06205121